COEUR D'ALENE, Idaho, July 8 /PRNewswire-FirstCall/ -- NightHawk Radiology Holdings, Inc. , the leading provider of radiology solutions to radiology groups and hospitals throughout the United States, today announced that its Board of Directors has authorized up to $10 million of share repurchases of its common stock. Under the program, repurchases may be made from time to time by the Company in the open market, in block purchases, or in solicited or unsolicited privately negotiated transactions in accordance with Securities and Exchange Commission (SEC) rules and subject to factors such as market price, the Company's operating results and available cash, general economic and market conditions, and other considerations the company deems prudent.
Dr. Paul Berger, Chairman and Chief Executive Officer of NightHawk, stated, "NightHawk's Board of Directors believes that repurchasing shares in the current marketplace represents a good investment for the company and we believe this stock repurchase program will help enhance long-term shareholder value."
NightHawk Radiology , headquartered in Coeur d'Alene, Idaho, is leading the transformation of the practice of radiology by providing high-quality, cost-effective solutions to radiology groups and hospitals throughout the United States. NightHawk provides the most complete suite of solutions, including professional services, business services, and its advanced, proprietary clinical workflow technology, all designed to increase efficiencies and improve the quality of patient care and the lives of physicians who provide it. NightHawk's team of U.S. board-certified, state-licensed, and hospital-privileged physicians located in the United States, Australia, and Switzerland, provides services 24 hours a day, seven days a week, for more than 750 radiology group customers and the 26% of all U.S. hospitals they serve. For more information, visit http://www.nighthawkrad.net.
This press release contains forward-looking statements, such as references to the authorization of the stock repurchase, the timing related thereto and expectations of long-term shareholder value. These statements, including their underlying assumptions, are subject to risk and uncertainties and are not guarantees of future performance. Results may differ due to various factors, such as the possibility that the amount authorized is not purchased. For further details of these risks, you should read our filings with the Securities and Exchange Commission. The statements presented in this press release speak only as of the date of the release. Except as otherwise required by applicable law, NightHawk does not undertake any obligation to publicly update its forward-looking statements based on events or circumstances after the date hereof.
CONTACT: Press, Robert Minicucci of Warner Communications,
+1-603-488-5856, mobile, +1-339-206-1722, firstname.lastname@example.org; or
Investors, Andrea Clegg of NightHawk Radiology Holdings, Inc.,
+1-208-292-2818, 1-866-402-4295, email@example.com
Web site: http://www.nighthawkrad.net/